ArticleProceedings of the National Academy of Sciences of the United States of America2000

Glycosylphosphatidylinositol biosynthesis validated as a drug target for African sleeping sickness.

M A FergusonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.